The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The new prognostic index of advanced gastric cancer using the data from JCOG1013.
 
Daisuke Takahari
Honoraria - Bristol-Myers Squibb Japan; Daiichi Sankyo/UCB Japan; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Narikazu Boku
Honoraria - Bristol-Myers Squibb Japan; Daiichi-Sankyo; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Ono Pharmaceutical (Inst); Takeda (Inst)
 
Satoru Iwasa
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Merck Serono (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Zymeworks (Inst)
 
Junki Mizusawa
Employment - Pfizer (I)
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Tadayoshi Hashimoto
No Relationships to Disclose
 
Takaki Yoshikawa
Honoraria - AstraZeneca; BMS; Chugai Pharma; Daiichi Sankyo; EA Pharma; Johnson & Johnson/Janssen; Medtronic; Miyarisan pharmaceutical; MSD; Ono Pharmaceutical; Taiho Pharmaceutical; TERUMO
Consulting or Advisory Role - MSD Oncology; TERUMO
Research Funding - Lilly
 
Shigenori Kadowaki
Honoraria - Bayer; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; Lilly; Merck KGaA; MSD; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Janssen (Inst); Lilly (Inst); MSD (Inst); Nobelpharma (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Nozomu Machida
Honoraria - Bristol-Myers Squibb Japan; Daiichi Sankyo; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - AstraZeneca (Inst); MSD (Inst)
 
Kenji Ishido
No Relationships to Disclose
 
Masahiro Tsuda
No Relationships to Disclose
 
Takahiro Kinoshita
Honoraria - Bristol-Myers Squibb Japan; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson; Kaken Pharmaceutical; Lilly Japan; Medtronic; Olympus Medical Systems; Otsuka; Taiho Pharmaceutical; TERUMO; Tsumura & Co.
Travel, Accommodations, Expenses - Bristol-Myers Squibb Japan; Daiichi Sankyo; Johnson & Johnson K.K; Kaken Pharmaceutical; Lilly Japan; Medtronic; Olympus Medical Systems; Otsuka; Taiho Pharmaceutical
 
Takushi Yasuda
No Relationships to Disclose
 
Keisho Chin
Honoraria - Ono Pharmaceutical
Speakers' Bureau - Bristol-Myers Squibb; Ono Pharmaceutical
 
Hiroaki Hata
No Relationships to Disclose
 
Toshiyasu Ojima
No Relationships to Disclose
 
Yasuhide Yamada
Honoraria - Boehringer Ingelheim; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst)
 
Masanori Terashima
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson; Lilly; Medtronic; Olympus; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Ono Pharmaceutical (Inst)